Cover Image

Constructing a Personalized Treatment Rule for Initial Therapy in Early Parkinson's Disease

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Zachary P. Brehm, Ruth B. Schneider, Charles S. Venuto, Greta Smith, Cuong Tuan Pham, Michael P. McDermott, Ashkan Ertefaie
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Response to Comment on “Acute Pharmacodynamic Effects of Oral Levodopa on Blood Pressure in Parkinson’s Disease”
by: Katherine Longardner, et al.
Published: (2026)

Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy
by: Jennifer N. Clements, et al.
Published: (2026)

Cancer Therapy‐Induced Cardiotoxicity: A Narrative Review
by: Drew A. Wells, et al.
Published: (2026)

Harnessing the Power of Artificial Intelligence to Enhance Drug Therapy Research
by: William L. Baker, et al.
Published: (2026)

Bayesian Dosing Simulator ( BDS ): A Pharmacokinetic Modeling Tool for Optimized Antibiotic Therapy
by: Adrian Valadez, et al.
Published: (2026)

Predictors and Clinical Outcomes of Long‐Term Opioid Therapy in Older Adults: A Systematic Review
by: Iftekhar Ahmed, et al.
Published: (2026)

Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta‐Analysis
by: Daniela Gorski, et al.
Published: (2025)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
by: Amira R. Rashdan, et al.
Published: (2026)

Drug–Drug Interactions and Combination Therapy Strategies of Amiodarone With Digoxin, Rivaroxaban, and Phenytoin Assessed by Physiologically Based Pharmacokinetic Modeling
by: Youjun Chen, et al.
Published: (2025)

Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis
by: Wenqiang Zhou, et al.
Published: (2026)

Synthetic Data–Driven Early Prediction Framework for Acute Kidney Injury in Patients Receiving Vancomycin and Ceftazidime/Avibactam
by: Maryam Ramazani, et al.
Published: (2025)

GLP‐1RA‐induced delays in gastrointestinal motility: Predicted effects on coadministered drug absorption by PBPK analysis
by: Levi Hooper, et al.
Published: (2025)

Chloride dipstick to rapidly estimate urine sodium during diuresis in acute heart failure
by: Vacha Shah, et al.
Published: (2025)

Current and emerging PCSK9‐directed therapies to reduce LDL‐C and ASCVD risk: A state‐of‐the‐art review
by: Candice L. Garwood, et al.
Published: (2024)

ECLIPSES: Early initiation of sodium glucose cotransporter‐2 inhibitors for cardiovascular protection in patients with type 2 diabetes following acute coronary syndrome and subsequent coronary artery bypass graft surgery
by: Lena Makortoff, et al.
Published: (2024)

Pharmacokinetics of Sulbactam/Durlobactam in a Patient With Acute Renal Failure, Severe Obesity, and Carbapenem‐Resistant Acinetobacter baumannii Bacteremia: A Case Report
by: Dan Ilges, et al.
Published: (2025)

Severe Persistent Urinary Retention Following Treatment With Intravenous Lecanemab
by: Amber N. Navarra, et al.
Published: (2025)

Precision Daptomycin Dosing: Comparison of 3‐, 2‐, 1‐, and 0‐Concentration Sample Strategies
by: Simone Giuliano, et al.
Published: (2025)

Retrospective cohort study of oral switch versus intravenous antibiotics for carbapenem‐resistant enterobacterales and Pseudomonas aeruginosa infections on hospital discharge
by: Christen J. Arena, et al.
Published: (2025)

SGLT2 Inhibitors and GLP‐1 Receptor Agonists After Acute Kidney Injury: A Systematic Review With Meta‐Analysis
by: Erin F. Barreto, et al.
Published: (2026)

Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy
by: Elmar R. Alizadeh, et al.
Published: (2024)

Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Partial‐ and Full‐Thickness Skin Burns
by: Ronald G. Hall, et al.
Published: (2025)

Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis
by: C. Michael White, et al.
Published: (2024)

Pharmacokinetics of continuous infusion ceftolozane/tazobactam in two patients with extensive total body surface area burns
by: Jay D. Olivet, et al.
Published: (2025)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
by: Nihal El Rouby, et al.
Published: (2025)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
by: Alexandre Duong, et al.
Published: (2024)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
by: Maryam Aghakouchakzadeh, et al.
Published: (2026)

Cancer Treatment Modalities and Female Fertility Preservation
by: Seonga Song, et al.
Published: (2026)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
by: Mohammed Al Musawa, et al.
Published: (2024)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
by: Atif Siddiqui
Published: (2025)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
by: Jiwon Kim, et al.
Published: (2025)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
by: Hua‐Ping Fan, et al.
Published: (2024)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
by: Keith A. Rodvold
Published: (2026)

Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
by: Nicolette Centanni, et al.
Published: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
by: Yi‐Fan Chien, et al.
Published: (2025)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
by: Amanda Massmann, et al.
Published: (2025)

In Search of Big Beautiful Biomarkers
by: C. Lindsay DeVane
Published: (2025)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
by: Carlos Augusto Espinoza Cobeñas
Published: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
by: Lisa T. Hong, et al.
Published: (2024)

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
by: Trisha Matsuura, et al.
Published: (2025)